WASHINGTON, DC, July 18, 2024 – Alexander S. Mathews, President and CEO of the Animal Health Institute, has announced his intention to retire from that position at the end of the calendar year. As a result, the Board has initiated a nationwide search for a successor.  “The AHI Board extends its deepest gratitude to Alex […]

AHI Statement Regarding FDA-CVM Clarification

July 16, 2024 The Animal Health Institute (AHI) commends the Food and Drug Administration’s Center for Veterinary Medicine (FDA-CVM) for its decisive action in clarifying the prioritization of approved pioneer and generic products by veterinarians and pharmacists before considering compounded or illegally imported products. The use of FDA-approved animal drug products should always be preferred. These […]

Ester Banque of Zoetis Elected AHI Board Chair

WASHINGTON, DC, May 14, 2024 – The Animal Health Institute’s Board of Directors today elected Ester Banque of Zoetis as Board Chair for the 2024-26 term. Banque is Executive Vice President and President, U.S. Operations for Zoetis. Richard R. DeLuca, Jr., Executive Vice President and President, Merck Animal Health, becomes Immediate Past Chair and Joseph […]

AHI Position on Arizona’s mRNA Labeling Legislation

April 14, 2024 — AHI encourages Arizona Governor Katie Hobbs to veto SB 1146, a bill that disparages life-saving vaccine technology by allowing food products from aquaculture, livestock, and poultry to be labeled “mRNA free” if the animals did not receive mRNA vaccinations.  Labeling food mRNA free would be sending a false message to consumers. […]

AHI Welcomes FDA Action on Unapproved Drugs

(December 14, 2023) AHI welcomes the announcement of the Food and Drug Administration’s (FDA) action to issue warning letters to nine manufacturers and distributors who were marketing unapproved and misbranded antimicrobial animal drugs. This action is consistent with the work done by animal drug companies and FDA’s Center for Veterinary Medicine (CVM) to advance antimicrobial […]

Congress Supports Animal Health with Passage of ADUFA

The Animal Health Institute today praised Congress for passing the reauthorization of the Animal Drug User Fee Act (ADUFA).  ADUFA provides the Food and Drug Administration’s Center for Veterinary Medicine (CVM) with supplemental industry funds in exchange for meeting agreed-upon performance goals.  Originally established in 2004, this is the fifth authorization. AHI thanks the House […]

Alert: Ticks Can Cause Food Allergies

CDC data reveals that an aggressive tick may be the culprit in the increased instances of alpha-gal syndrome, or red-meat allergy, a potentially life-threatening condition that affects up to 450,000 people in the U.S. Carried by the lone star tick, those with red-meat allergy have reactions to meat such as beef, pork, and lamb. The […]


Washington, D.C. – March 30, 2023. The Animal Health Institute (AHI) joined veterinary medical experts to present testimony before the House Energy and Commerce Committee on the reauthorization of the Animal Drug User Fee Act (ADUFA). Dr. Rachel Cumberbatch, AHI Director of International and Regulatory Affairs, urged Congress to swiftly reauthorize the bill that enables […]

AHI Supports FDA Restructuring Announcement

January 31, 2023 The Animal Health Institute supports the restructuring announced by Food and Drug Commissioner Robert M. Califf. The new structure maintains the Center for Veterinary Medicine (CVM) as a stand-alone center while coordinating its food safety activities with the new Deputy Commissioner for Human Foods. “This is a practical and common-sense approach that […]

Animal Health Industry Reaches All-time High

A new study from NDP Analytics, The Economic and Social Contributions of the Animal Health Industry, details the growth of the animal health industry over the past three years and documents the value and role that the companies that produce animal medicines play in the U.S. economy and beyond. As other industries struggled because of […]